Higher expression of estrogen response genes in the primary tumor is associated with a greater risk for late recurrence in patients with ER1/HER2-breast cancer

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - Sept-2017
Event42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain
Duration: 8-Sept-201712-Sept-2017

Cite this